Company Filing History:
1 out of 285 
1 out of 5,111 
Years Active: 2018
Title: The Innovations of Mathieu Galibert
Introduction
Mathieu Galibert is a notable inventor based in Orleans, France. He has made significant contributions to the field of biotechnology, particularly in the area of reproductive health. His work has led to the development of innovative compounds that have the potential to impact mammalian ovulation.
Latest Patents
Galibert holds a patent for KISS1R receptor agonist compounds and their use for inducing ovulation in mammals. This patent describes a KISS1R agonist peptide compound capable of inducing ovulation in female mammals. The compound is a pseudopeptide characterized by a specific C-terminal sequence, which includes a 1,4-disubstituted 1,2,3-triazole group. This innovative approach to inducing ovulation could have significant implications for reproductive technologies.
Career Highlights
Throughout his career, Mathieu Galibert has worked with prestigious research institutions. He has been associated with the National Institute for Agronomic Research and the National Center for Scientific Research. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Galibert has collaborated with several notable individuals in his field, including Massimiliano Beltramo and Vincent Aucagne. These collaborations have enriched his research and expanded the impact of his innovations.
Conclusion
Mathieu Galibert's contributions to the field of biotechnology, particularly through his patent on KISS1R receptor agonist compounds, highlight his role as an influential inventor. His work continues to pave the way for advancements in reproductive health.